Description:

CALGB: 40301 TREATMENT SUMMARY FORM (SUBSET OF PATIENTS) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E5A00141-D565-5413-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E5A00141-D565-5413-E034-0003BA3F9857

Keywords:

Clinical Trial

Treatment Form

Breast Neoplasms

Versions (3) ▾

8/27/12
1/9/15
6/16/15

Uploaded on:

June 16, 2015

DOI:

No DOI assigned. To request one please log in.

License:

Creative Commons BY-NC 3.0 Legacy

Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

CALGB: 40301 TREATMENT SUMMARY FORM (SUBSET OF PATIENTS)

Details

INSTRUCTIONS: Complete and submit this form as required by the protocol. Information in the upper right box must be completed for this form to be accepted. For optimal accuracy use black ink.

StudyEvent: CALGB: 40301 TREATMENT SUMMARY FORM (SUBSET OF PATIENTS)
1. INSTRUCTIONS: Complete and submit this form as required by the protocol. Information in the upper right box must be completed for this form to be accepted. For optimal accuracy use black ink.

Header

CALGB Form

CALGB Study No

CALGB Patient ID

Last date of reporting period

Are data amended

Yes

Patient demographics

Patient Initials

Patient Hospital No

Institution/Affiliate

Participating Group

Participating Group Protocol No

Participating Group Patient ID

Assessment of Chemotherapy

Cycle start date

Current cycle number (Tipifarnib/Placebo)

Number of tablets issued

Dose

Cycle end date

Number of tablets remaining

Were there any dose modifications or additions/omissions to protocol treatment (Tipifarnib or Placebo)

No (No)

Yes, Planned (i.e., The Treatment Was Changed According To Protocol Guidelines) (Yes, planned)

Yes, Unplanned (i.e., The Treatment Change Was Not Part Of Protocol Guidelines) (Yes, unplanned)

Unknown (Unknown)

specify reason why (If Yes)

Completed by

Date form completed

Back to the top of the page

Similar models

Show recommended models